Oxibendazole

DB04910ExperimentalVet approvedSmall molecule

Oxibendazole is a polymerase inhibitor in phase III trials for the treatment of helminth intestinal infections.

Chemical structure of Oxibendazole
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in infectious and parasitic disease (unspecified) and pediatric indications.Curator reviewed
Formula / weight
C12H15N3O3 · 249.2658 g/mol (avg)
Code names
SK&F-30310

Resolves to

Clinical / RWD
Structure
InChIKeyRAOCRURYZCVHMG-UHFFFAOYSA-NSMILESCCCOC1=CC2=C(C=C1)N=C(NC(=O)OC)N2

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxibendazole, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account